GOUT
Clinical trials for GOUT explained in plain language.
Never miss a new study
Get alerted when new GOUT trials appear
Sign up with your email to follow new studies for GOUT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New gout drug HEC93077 passes early safety tests in chinese volunteers
Disease control CompletedThis early-stage trial tested a new drug called HEC93077 in 126 healthy Chinese volunteers and people with high uric acid (hyperuricemia), a condition that can lead to gout. The main goals were to check the drug's safety, how the body processes it, and whether food affects its ab…
Matched conditions: GOUT
Phase: PHASE1 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 05:54 UTC
-
New gout pill AR882 shows promise in major trial
Disease control CompletedThis study tested a new drug called AR882 in 818 adults with gout. The goal was to see if AR882 lowers uric acid levels better than a placebo over 12 months. Participants took either a low or high dose of AR882 or a placebo pill. The main measure was how many people reached a saf…
Matched conditions: GOUT
Phase: PHASE3 • Sponsor: Arthrosi Therapeutics • Aim: Disease control
Last updated May 26, 2026 05:50 UTC
-
New gout pill shows promise in major trial
Disease control CompletedThis study tested a new medicine called tigulixostat in 354 adults with gout and high uric acid levels. The goal was to see if taking the drug for 6 months could safely lower uric acid below a target level. Participants received either one of three doses of tigulixostat or a plac…
Matched conditions: GOUT
Phase: PHASE3 • Sponsor: LG Chem • Aim: Disease control
Last updated May 26, 2026 05:48 UTC
-
New gout drug shows promise in lowering uric acid levels
Disease control CompletedThis study tested a new medicine called LC350189 in 156 adults with gout and high uric acid. The goal was to see if the drug could safely lower uric acid levels over 12 weeks. Participants received one of three doses of the new drug, a placebo, or an active comparator. The main m…
Matched conditions: GOUT
Phase: PHASE2 • Sponsor: LG Chem • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New gout drug shows promise in lowering uric acid
Disease control CompletedThis study tested a new medicine called ABP-671 for people with gout, a painful form of arthritis caused by high uric acid levels. About 300 adults took part to see if ABP-671 could safely lower uric acid below a target level. The drug was compared to a placebo and an older gout …
Matched conditions: GOUT
Phase: PHASE2, PHASE3 • Sponsor: Atom Therapeutics Co., Ltd • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Could less frequent infusions tame tough gout?
Disease control CompletedThis study tested whether a gout medication (pegloticase) given every 4 weeks with methotrexate works as well as the standard every-2-week schedule for people with hard-to-control gout. About 262 adults with uncontrolled gout took part. The goal was to see if the less frequent do…
Matched conditions: GOUT
Phase: PHASE4 • Sponsor: Amgen • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
New gout drug epaminurad takes on febuxostat in major trial
Disease control CompletedThis phase 3 trial tested a new gout drug, epaminurad, against the standard treatment febuxostat in 612 adults with gout. The goal was to see which drug better lowers uric acid levels below 6 mg/dL. Participants took one of the two medications for several months, and researchers …
Matched conditions: GOUT
Phase: PHASE3 • Sponsor: JW Pharmaceutical • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
Could a quicker gout infusion be just as safe and effective?
Disease control CompletedThis study looked at whether giving the gout medication pegloticase over a shorter time is safe and works well for people with uncontrolled gout who are also taking methotrexate. About 191 adults took part. The main goal was to check for infusion reactions, and a key measure was …
Matched conditions: GOUT
Phase: PHASE4 • Sponsor: Amgen • Aim: Disease control
Last updated May 18, 2026 11:59 UTC
-
Can a phone call ease arthritis pain? new study says yes
Symptom relief CompletedThis study tested a phone-based version of the Walk With Ease program for 267 adults with arthritis, gout, fibromyalgia, or lupus. Participants received coaching over the phone to help them walk more and manage symptoms. The goal was to see if this approach could reduce pain and …
Matched conditions: GOUT
Phase: NA • Sponsor: University of South Carolina • Aim: Symptom relief
Last updated May 26, 2026 05:56 UTC
-
Gout drugs may hold key to Alzheimer's prevention
Knowledge-focused CompletedThis study looked at medical records from nearly 295,000 older adults with gout to see if two common gout medications, probenecid and allopurinol, affect the risk of developing Alzheimer's or other dementias. The goal was to find out if either drug could be repurposed to protect …
Matched conditions: GOUT
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 05:50 UTC
-
Do kidney donors face higher gout risk? new study investigates.
Knowledge-focused CompletedThis study looked at whether people who donate a kidney have a higher chance of developing gout later in life. Researchers compared 50,000 living kidney donors to similar healthy people who did not donate. They used health records from three Canadian provinces to track gout diagn…
Matched conditions: GOUT
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Knowledge-focused
Last updated May 26, 2026 05:49 UTC
-
Gout imaging showdown: which scan best tracks crystal buildup?
Knowledge-focused CompletedThis study looked at 60 adults with gout who were starting medication to lower uric acid. Researchers compared two types of scans—ultrasound and DECT—to see how well they measured changes in urate crystal deposits over 24 months. The goal was to find out which imaging method work…
Matched conditions: GOUT
Phase: NA • Sponsor: Lille Catholic University • Aim: Knowledge-focused
Last updated May 26, 2026 05:47 UTC
-
Stick-On patch could track gout levels without needles
Knowledge-focused CompletedThis study tested a new skin patch that measures uric acid levels in people with gout. Six participants wore the patch during a meal and for 7 days at home. The goal was to see if the patch is comfortable and can accurately track uric acid and other substances. This is an early t…
Matched conditions: GOUT
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated May 26, 2026 05:47 UTC
-
Polynesian gout mystery: scientists hunt for genetic clues in families
Knowledge-focused CompletedThis study looked at 33 Polynesian adults from families with multiple gout cases to find genetic factors that increase gout risk. Researchers compared gout patients with their non-gouty relatives and used advanced CT scans to detect early crystal deposits. The goal is to better u…
Matched conditions: GOUT
Phase: NA • Sponsor: Lille Catholic University • Aim: Knowledge-focused
Last updated May 26, 2026 05:46 UTC
-
Scientists hunt for genes behind rare kidney diseases
Knowledge-focused CompletedThis study aimed to find the genetic causes of certain inherited kidney diseases that run in families. Researchers studied 225 adults with chronic kidney failure and gout, looking for mutations in known genes and searching for new ones. The goal was to better understand these rar…
Matched conditions: GOUT
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 26, 2026 05:44 UTC
-
18,000-Person study reveals vegetarian Diet's impact on chronic disease risk
Knowledge-focused CompletedThis study followed over 18,000 Taiwanese adults to see if a vegetarian diet is linked to a lower risk of chronic diseases like dementia, depression, heart disease, stroke, gout, cataracts, gallstones, and urinary tract infections. Researchers used health insurance records to tra…
Matched conditions: GOUT
Sponsor: Dalin Tzu Chi General Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 05:42 UTC
-
Why is gout so common in french polynesia? scientists investigate
Knowledge-focused CompletedThis study looked at how common gout is in French Polynesia and what genetic factors might cause it. Over 1,000 adults from several islands took part. Researchers measured gout rates and searched for genetic links to better understand why Polynesians have higher rates of this pai…
Matched conditions: GOUT
Phase: NA • Sponsor: Lille Catholic University • Aim: Knowledge-focused
Last updated May 20, 2026 12:00 UTC
-
Nursing home study reveals hidden joint pain in dementia patients
Knowledge-focused CompletedThis study looked at how often nursing home residents over 65 have joint complaints like pain or swelling. Researchers examined 100 residents, some with dementia and some without, to count tender or swollen joints. The goal was to better understand these issues in a group that is…
Matched conditions: GOUT
Sponsor: Maastricht University Medical Center • Aim: Knowledge-focused
Last updated May 13, 2026 16:00 UTC